Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults

S. Daenen; B. van der Holt; G.E. Verhoef; B. Löwenberg; P.W. Wijermans; P.C. Huijgens; M. van Marwijk-Kooy; H.C. Schouten; M.H.H. Kramer; A. Ferrant; E. van den Berg; M.M.C. Steijaert; L.F. Verdonck; P. Sonneveld

Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults

Translated title of the contribution: Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults

S. Daenen
, B. van der Holt
, G.E. Verhoef
, B. Löwenberg
, P.W. Wijermans
, P.C. Huijgens
, M. van Marwijk-Kooy
, H.C. Schouten
, M.H.H. Kramer
, A. Ferrant
, E. van den Berg
, M.M.C. Steijaert
, L.F. Verdonck
, P. Sonneveld

Hematology/Van Creveldclinic

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults
Original language	Undefined/Unknown
Pages (from-to)	1057-1067
Number of pages	11
Journal	Leukemia Research
Volume	28
Publication status	Published - 2004

Cite this

Daenen, S., van der Holt, B., Verhoef, G. E., Löwenberg, B., Wijermans, P. W., Huijgens, P. C., van Marwijk-Kooy, M., Schouten, H. C., Kramer, M. H. H., Ferrant, A., van den Berg, E., Steijaert, M. M. C., Verdonck, L. F., & Sonneveld, P. (2004). Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults. Leukemia Research, 28, 1057-1067.

Daenen, S. ; van der Holt, B. ; Verhoef, G.E. et al. / Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults. In: Leukemia Research. 2004 ; Vol. 28. pp. 1057-1067.

@article{76de724612af459ea9ba2a5ae9d7b833,

title = "Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults",

author = "S. Daenen and \{van der Holt\}, B. and G.E. Verhoef and B. L{\"o}wenberg and P.W. Wijermans and P.C. Huijgens and \{van Marwijk-Kooy\}, M. and H.C. Schouten and M.H.H. Kramer and A. Ferrant and \{van den Berg\}, E. and M.M.C. Steijaert and L.F. Verdonck and P. Sonneveld",

year = "2004",

language = "Undefined/Unknown",

volume = "28",

pages = "1057--1067",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Limited",

}

Daenen, S, van der Holt, B, Verhoef, GE, Löwenberg, B, Wijermans, PW, Huijgens, PC, van Marwijk-Kooy, M, Schouten, HC, Kramer, MHH, Ferrant, A, van den Berg, E, Steijaert, MMC, Verdonck, LF & Sonneveld, P 2004, 'Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults', Leukemia Research, vol. 28, pp. 1057-1067.

Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults. / Daenen, S.; van der Holt, B.; Verhoef, G.E. et al.
In: Leukemia Research, Vol. 28, 2004, p. 1057-1067.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults

AU - Daenen, S.

AU - van der Holt, B.

AU - Verhoef, G.E.

AU - Löwenberg, B.

AU - Wijermans, P.W.

AU - Huijgens, P.C.

AU - van Marwijk-Kooy, M.

AU - Schouten, H.C.

AU - Kramer, M.H.H.

AU - Ferrant, A.

AU - van den Berg, E.

AU - Steijaert, M.M.C.

AU - Verdonck, L.F.

AU - Sonneveld, P.

PY - 2004

Y1 - 2004

M3 - Article

SN - 0145-2126

VL - 28

SP - 1057

EP - 1067

JO - Leukemia Research

JF - Leukemia Research

ER -

Daenen S, van der Holt B, Verhoef GE, Löwenberg B, Wijermans PW, Huijgens PC et al. Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults. Leukemia Research. 2004;28:1057-1067.